Posted by Michael Wonder on 05 Jun 2021
Chimerix receives U.S. FDA approval for Tembexa (brincidofovir) for the treatment of smallpox
4 June 2021 - First smallpox anti-viral approved for all age groups, including infants, and patients who have difficulty swallowing.
Chimerix today announced that the U.S. FDA has granted Tembexa (brincidofovir) tablets and oral suspension approval for the treatment of smallpox.
